Stuart A. Green

Amino-Terminal Polymorphisms of the Human .beta.2-Adrenergic Receptor Impart Distinct Agonist-Promoted Regulatory Properties

Stuart A. Green, J Turki, Michael A. Innis et al. · Biochemistry · 1994 · 773 citations

Genetics, Molecular Pharmacology, Adrenal Gland +16

A Gain-of-function Polymorphism in a G-protein Coupling Domain of the Human β1-Adrenergic Receptor

Deborah A. Mason, Jason D. Moore, Stuart A. Green et al. · Journal of Biological Chemistry · 1999 · 585 citations · Full text

Gain-of-function Polymorphism, Neuropeptides, Arg-389 Receptors +18

cAMP-Dependent Regulation of Cardiac L-Type Ca2+ Channels Requires Membrane Targeting of PKA and Phosphorylation of Channel Subunits

Tianyan Gao, Atsuko Yatani, Mark L. Dell’Acqua et al. · Neuron · 1997 · 514 citations

Cardiac Muscle, Channelopathies, Cardiomyopathy +11

Efficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials

Lorcan McGarvey, Surinder S. Birring, Alyn H. Morice et al. · The Lancet · 2022 · 286 citations

Asthma, Medicine, Clinical Trials +6

Complications of External Skeletal Fixation

Stuart A. Green · Clinical Orthopaedics and Related Research · 1983 · 258 citations

Engineering, Surgery, Biomedical Engineering +19